Recruiting

MAUD with Counseling

Sponsor:

Yale University

Code:

NCT07525258

Conditions

Alcohol Use Disorder

Alcohol-associated Liver Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Implementation Intervention

Study Details

Brief summary:

The goal of this project is to improve provision of integrated medications for alcohol use disorder (MAUD) with brief counseling for patients with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD) in hepatology clinics. There are many benefits of AUD treatment among patients with AUD and ALD such as reduction in liver-related complications and hepatology clinicians providing this care in an integrated fashion can improve access and uptake.

Conditions

Alcohol Use Disorder

Alcohol-associated Liver Disease

Study ID

NCT07525258

Start date

Apr 5, 2026

Status verified date

May, 2026

Completion date

Apr, 2029

Anticipated

Primary completion date

Apr, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Must provide care for patients with liver disease at a hepatology clinical location within the Yale School of Medicine and YNHH medical system.

Exclusion Criteria:

  • Providers who do not treat patients with chronic liver disease and alcohol-associated liver disease.

Study Design

Enrollment

30 participants

Anticipated

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Hepatology Clinicians

Clinician participants will participate in a multipronged intervention including hepatology clinician education, patient education, clinical decision support, and clinician audit and feedback which will be adapted and tested. Participants will attend two approximately 60-minute-long educational sessions in which key points related to AUD treatment based on the HPCR resource and implementation facilitation intervention will be reviewed.

Interventions

Implementation Intervention

A multipronged intervention including hepatology clinician education, patient education, clinical decision support, and clinician audit and feedback which will be adapted and tested.

Primary outcome measure

  • Feasibility [ Time Frame: 12 months ]

Central Contacts and Locations

Central contacts

Lamia Haque, MD MPH

(203) 777-0304lamia.haque@yale.edu

Locations

Yale School of Medicine/Yale-New Haven Health

Recruiting

New Haven, Connecticut, United States, 06520

More Information

Sponsor

Yale University

Last update posted

May 7, 2026

Last verified

May, 2026

Keywords

  • Clinicians
  • Medications for Alcohol Use Disorder

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Yale University on 2026-05-07.